Raymond James Maintains Outperform on Exact Sciences, Lowers Price Target to $70

Raymond James analyst Andrew Cooper maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $80 to $70.

Raymond James analyst Andrew Cooper maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $80 to $70.

Total
0
Shares
Related Posts